心脏植入式电子设备：生命末期的生物伦理学与管理问题
Cardiac implantable electrical devices: bioethics and management issues near the end of life.
作者信息
Abi-Samra Freddy M
机构信息
Director, Cardiac Electrophysiology Laboratories, Department of Cardiology, Ochsner Clinic Foundation, New Orleans, LA.
出版信息
Ochsner J. 2011 Winter;11(4):342-7.
Abstract
Cardiac implantable electrical devices (CIEDs) are extremely sophisticated modern devices that provide patients with many beneficial effects, including increased survival and enhanced quality of life. CIEDs, however, may complicate and unnecessarily prolong the process of dying from terminal illnesses. A rational plan for CIED deactivation near the end of life should therefore be carefully drawn up well in advance by the patient in concert with loved ones and treating physicians.
摘要
心脏植入式电子设备（CIEDs）是极其复杂的现代设备，能给患者带来诸多益处，包括提高生存率和改善生活质量。然而，CIEDs可能会使晚期疾病患者的死亡过程变得复杂且不必要地延长。因此，患者应在生命末期与亲人及主治医生提前精心制定合理的CIED停用计划。
相似文献
1
Cardiac implantable electrical devices: bioethics and management issues near the end of life.心脏植入式电子设备：生命末期的生物伦理学与管理问题
Ochsner J. 2011 Winter;11(4):342-7.
2
Ethical and legal views regarding deactivation of cardiac implantable electrical devices in patients with hypertrophic cardiomyopathy.关于肥厚型心肌病患者心脏植入式电子设备去激活的伦理和法律观点。
Am J Cardiol. 2011 Apr 1;107(7):1071-1075.e5. doi: 10.1016/j.amjcard.2010.11.036. Epub 2011 Feb 4.
3
Cardiovascular implantable electronic devices: patient education, information and ethical issues.心血管植入式电子设备：患者教育、信息及伦理问题
Med Law. 2012 Sep;31(3):355-63.
4
Safety of lung stereotactic ablative radiotherapy for the functioning of cardiac implantable electronic devices.肺立体定向消融放疗对心脏植入式电子设备功能的安全性。
Radiother Oncol. 2021 Mar;156:193-198. doi: 10.1016/j.radonc.2020.12.029. Epub 2020 Dec 30.
5
Cardiac Implantable Electronic Device Therapy: Permanent Pacemakers, Implantable Cardioverter Defibrillators, and Cardiac Resynchronization Devices.心脏植入式电子设备治疗：永久性起搏器、植入式心脏复律除颤器和心脏再同步治疗装置。
Med Clin North Am. 2019 Sep;103(5):931-943. doi: 10.1016/j.mcna.2019.04.005. Epub 2019 Jul 5.
6
7
[Device therapy in cardiological palliative care situations].[心脏病姑息治疗中的设备疗法]
Herzschrittmacherther Elektrophysiol. 2019 Jun;30(2):204-211. doi: 10.1007/s00399-019-0623-1.
8
Complications arising from cardiac implantable electrophysiological devices: review of epidemiology, pathogenesis and prevention for the clinician.心脏植入式电生理设备引发的并发症：临床医生对流行病学、发病机制及预防的综述
Postgrad Med. 2016;128(2):223-30. doi: 10.1080/00325481.2016.1151327. Epub 2016 Feb 22.
9
10
Radiotherapy is safe in patients with implantable cardiac devices. Analysis of a systematic interrogation follow-up.放射治疗在植入式心脏装置患者中是安全的。系统询问随访分析。
Clin Transl Oncol. 2020 Dec;22(12):2286-2292. doi: 10.1007/s12094-020-02374-y. Epub 2020 May 17.
引用本文的文献
1
Smartphone Imaging and AI: A Commentary on Cardiac Device Classification.智能手机成像与人工智能：关于心脏设备分类的评论
Radiol Artif Intell. 2024 Sep;6(5):e240418. doi: 10.1148/ryai.240418.
2
Evolution of Pacemakers and Implantable Cardioverter Defibrillators (ICDs) in Cardiology.心脏病学中起搏器和植入式心脏复律除颤器（ICD）的发展历程
Cureus. 2023 Oct 2;15(10):e46389. doi: 10.7759/cureus.46389. eCollection 2023 Oct.
3
In vitro evaluation of blood plasma coagulation responses to four medical-grade polyurethane polymers.体外评估四种医用级聚氨酯聚合物对血浆凝血反应的影响。
J Biomater Appl. 2023 Aug;38(2):302-310. doi: 10.1177/08853282231191410. Epub 2023 Jul 20.
4
The Quality of Life in Patients With Implantable Cardiac Devices: A Single-Center Cross-Sectional Study.植入式心脏装置患者的生活质量：一项单中心横断面研究。
Cureus. 2021 Oct 6;13(10):e18542. doi: 10.7759/cureus.18542. eCollection 2021 Oct.
5
Biomarkers in the management of acute heart failure: state of the art and role in COVID-19 era.急性心力衰竭管理中的生物标志物：现状和在 COVID-19 时代的作用。
ESC Heart Fail. 2021 Dec;8(6):4465-4483. doi: 10.1002/ehf2.13595. Epub 2021 Oct 5.
6
Ethical challenges of deactivation of cardiac devices in advanced heart failure.晚期心力衰竭中心脏设备停用的伦理挑战
Curr Heart Fail Rep. 2014 Jun;11(2):119-25. doi: 10.1007/s11897-014-0194-8.
7
Recent publications by ochsner authors.奥克斯纳作者近期发表的作品。
Ochsner J. 2012 Summer;12(2):175-80.
本文引用的文献
1
Epidemiology of sudden cardiac death in patients with heart failure.心力衰竭患者心源性猝死的流行病学。
Heart Fail Clin. 2011 Apr;7(2):147-55, vii. doi: 10.1016/j.hfc.2010.12.008.
2
Ethical and legal views regarding deactivation of cardiac implantable electrical devices in patients with hypertrophic cardiomyopathy.关于肥厚型心肌病患者心脏植入式电子设备去激活的伦理和法律观点。
Am J Cardiol. 2011 Apr 1;107(7):1071-1075.e5. doi: 10.1016/j.amjcard.2010.11.036. Epub 2011 Feb 4.
3
Cardiac-resynchronization therapy for mild-to-moderate heart failure.心脏再同步治疗轻中度心力衰竭。
N Engl J Med. 2010 Dec 16;363(25):2385-95. doi: 10.1056/NEJMoa1009540. Epub 2010 Nov 14.
4
EHRA Expert Consensus Statement on the management of cardiovascular implantable electronic devices in patients nearing end of life or requesting withdrawal of therapy.EHRA 专家共识声明：心血管植入式电子设备在临近生命终末期或要求撤疗患者中的管理。
Europace. 2010 Oct;12(10):1480-9. doi: 10.1093/europace/euq275. Epub 2010 Jul 30.
5
Ethical and legal views of physicians regarding deactivation of cardiac implantable electrical devices: a quantitative assessment.医生对心脏植入式电子设备去激活的伦理和法律观点：定量评估。
Heart Rhythm. 2010 Nov;7(11):1537-42. doi: 10.1016/j.hrthm.2010.07.018. Epub 2010 Jul 19.
6
HRS Expert Consensus Statement on the Management of Cardiovascular Implantable Electronic Devices (CIEDs) in patients nearing end of life or requesting withdrawal of therapy.关于临终或要求停止治疗的患者心血管植入式电子设备（CIEDs）管理的HRS专家共识声明。
Heart Rhythm. 2010 Jul;7(7):1008-26. doi: 10.1016/j.hrthm.2010.04.033. Epub 2010 May 14.
7
Prevention of disease progression by cardiac resynchronization therapy in patients with asymptomatic or mildly symptomatic left ventricular dysfunction: insights from the European cohort of the REVERSE (Resynchronization Reverses Remodeling in Systolic Left Ventricular Dysfunction) trial.心脏再同步治疗对无症状或轻度症状性左心室功能不全患者疾病进展的预防作用：来自欧洲队列的REVERSE（收缩期左心室功能不全再同步逆转重塑）试验的见解
J Am Coll Cardiol. 2009 Nov 10;54(20):1837-46. doi: 10.1016/j.jacc.2009.08.011. Epub 2009 Oct 1.
8
Cardiac-resynchronization therapy for the prevention of heart-failure events.心脏再同步治疗预防心力衰竭事件
N Engl J Med. 2009 Oct 1;361(14):1329-38. doi: 10.1056/NEJMoa0906431. Epub 2009 Sep 1.
9
A blended sensor restores chronotropic response more favorably than an accelerometer alone in pacemaker patients: the LIFE study results.在起搏器患者中，混合传感器比单独使用加速度计更有利于恢复变时性反应：LIFE研究结果。
Pacing Clin Electrophysiol. 2008 Nov;31(11):1433-42. doi: 10.1111/j.1540-8159.2008.01207.x.
10
Impact of rate-modulated pacing on quality of life and exercise capacity--evidence from the Advanced Elements of Pacing Randomized Controlled Trial (ADEPT).频率调制起搏对生活质量和运动能力的影响——来自起搏随机对照试验高级要素（ADEPT）的证据。
Heart Rhythm. 2007 Sep;4(9):1125-32. doi: 10.1016/j.hrthm.2007.05.021. Epub 2007 Jun 2.
Zotero 插件